Global and United States BHK-21 Cells Market Report & Forecast 2022-2028
1 Study Coverage
- 1.1 BHK-21 Cells Revenue in BHK-21 Cells Business (2017-2022) & (US$ Million) Introduction
- 1.2 Global BHK-21 Cells Outlook 2017 VS 2022 VS 2028
- 1.2.1 Global BHK-21 Cells Market Size for the Year 2017-2028
2 BHK-21 Cells by Type
- 2.1 BHK-21 Cells Market Segment by Type
- 2.1.1 With Culture Medium
3 BHK-21 Cells by Application
- 3.1 BHK-21 Cells Market Segment by Application
- 3.1.1 Life Science Research
4 Global BHK-21 Cells Competitor Landscape by Company
- 4.1 Global BHK-21 Cells Market Size by Company
- 4.1.1 Top Global BHK-21 Cells Companies Ranked by Revenue (2021)
5 Global BHK-21 Cells Market Size by Region
- 5.1 Global BHK-21 Cells Market Size by Region: 2017 VS 2022 VS 2028
- 5.2 Global BHK-21 Cells Market Size by Region (2017-2028)
- 5.2.1 Global BHK-21 Cells Market Size by Region: 2017-2022
6 Segment in Region Level & Country Level
- 6.1 North America
- 6.1.1 North America BHK-21 Cells Market Size YoY Growth 2017-2028
7 Company Profiles
- 7.1 Creative Biolabs
- 7.1.1 Creative Biolabs Company Details
8 Research Findings and Conclusion
9 Appendix
- 9.1 Research Methodology
- 9.1.1 Methodology/Research Approach
The most widely used line is a subclone (clone 13) of BHK21, usually called as BHK 21(C13), which has been involved in the commercial manufacture of foot and mouth disease vaccines over a twenty year period. BHK-21 cells are susceptible to multiple viruses, including human adenovirus D, reovirus 3, vesicular stomatitis virus and so on.
Market Analysis and Insights: Global and United States BHK-21 Cells Market
This report focuses on global and United States BHK-21 Cells market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global BHK-21 Cells market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, With Culture Medium accounting for % of the BHK-21 Cells global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Life Science Research was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the BHK-21 Cells market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
Global BHK-21 Cells Scope and Market Size
BHK-21 Cells market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global BHK-21 Cells market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the BHK-21 Cells market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the BHK-21 Cells market is segmented into
With Culture Medium
Without Culture Medium
Segment by Application, the BHK-21 Cells market is segmented into
Life Science Research
Biopharmaceutical
Regional and Country-level Analysis
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and BHK-21 Cells Market Share Analysis
BHK-21 Cells market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in BHK-21 Cells business, the date to enter into the BHK-21 Cells market, Revenue in BHK-21 Cells Business (2017-2022) & (US$ Million) introduction, recent developments, etc.
The major vendors covered:
Creative Biolabs
ATCC
Merck
Procell Life Science&Technology
Obio Technology
WheLab
Nanjing Cobioer Biosciences
Boster Biological Technology